Viridian Therapeutics
VRDN
#5321
Rank
HK$8.37 B
Marketcap
HK$102.78
Share price
-2.28%
Change (1 day)
0.73%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -HK$38.17

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$37.77. In 2022 the company made an earnings per share (EPS) of -HK$31.26 an increase over its 2021 EPS that were of -HK$58.79.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$38.1722.12%
2022-HK$31.26-46.83%
2021-HK$58.79-73.94%
2020-HK$225.6444.73%
2019-HK$155.9122.94%
2018-HK$126.82-27.33%
2017-HK$174.52-91.47%
2016-HK$2,045-19.17%
2015-HK$2,531-75.48%
2014-HK$10,321582.47%
2013-HK$1,512

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.91-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA